Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Rosen Law Firm sues Medpace
Business class action lawsuit

Rosen Law Firm sues Medpace

Analysis based on 74 articles · First reported Apr 08, 2026 · Last updated Jun 08, 2026

Sentiment
-30
Attention
4
Articles
74
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is impacted by the potential financial liabilities for Medpace due to the class action lawsuit, which could lead to a decrease in its stock price. Investors who purchased Medpace stock during the Class Period may be entitled to compensation, affecting their investment returns.

pharmaceuticals legal services
Event Summary

Rosen Law Firm is actively encouraging investors to join a class action lawsuit against Medpace Holdings, Inc. The lawsuit alleges that Medpace made false and misleading statements and concealed material adverse facts concerning its backlog cancellation rate between April 22, 2025, and February 9, 2026. Medpace reportedly touted 'well behaved' cancellation rates and provided overly positive growth expectations, specifically a 1.15 book-to-bill ratio, which the lawsuit claims could not be maintained. Investors who purchased Medpace common stock during this period are encouraged to secure counsel before the June 8, 2026, lead plaintiff deadline. Philip Kim and Lawrence Rosen of Rosen Law Firm are key contacts for this action.

Key Actions
100 Bronstein, Gewirtz & Grossman, LLC filed class action lawsuit Medpace
97 Rosen Law Firm announces class action lawsuit Medpace
95 Faruqi & Faruqi investigating potential claims Medpace
95 Robbins Geller Rudman & Dowd LLP announced class action Medpace
94 The Schall Law Firm reminded investors of lawsuit Medpace
90 Medpace made false statements
Entities Involved
stock
Medpace
Medpace is the defendant in a class action lawsuit alleging that it made false and misleading statements regarding its backlog cancellation rates, leading to investor damages.
Importance 100 Sentiment -40
priv
Rosen Law Firm
Rosen Law Firm is initiating and encouraging investors to join a class action lawsuit against Medpace, seeking compensation for alleged investor damages.
Importance 90 Sentiment 20
priv
Bronstein, Gewirtz & Grossman, LLC
Bronstein, Gewirtz & Grossman, LLC is the law firm that filed the class action lawsuit against Medpace, representing investors and seeking to recover damages.
Importance 90 Sentiment 60
priv
The Schall Law Firm
The Schall Law Firm is representing investors in a class action lawsuit against Medpace, encouraging shareholders to join the case to recover losses.
Importance 80 Sentiment 20
priv
Faruqi & Faruqi
Faruqi & Faruqi is a national securities law firm investigating potential claims against Medpace and reminding investors of the deadline to seek lead plaintiff status in the class action lawsuit.
Importance 80 Sentiment 50
per
Philip Kim
Philip Kim is an attorney at Rosen Law Firm and is a contact person for investors interested in joining the Medpace class action lawsuit.
Importance 70 Sentiment 10
priv
Robbins Geller Rudman & Dowd LLP
Robbins Geller Rudman & Dowd LLP is another law firm that has announced a class action lawsuit against Medpace and is seeking lead plaintiffs.
Importance 70 Sentiment 35
per
Lawrence Rosen
Lawrence Rosen is a founding partner of Rosen Law Firm, which is leading the class action lawsuit against Medpace.
Importance 60 Sentiment 10
per
Brian Schall
Brian Schall is an attorney at The Schall Law Firm, encouraging investors to contact him regarding the class action lawsuit against Medpace.
Importance 60 Sentiment 10
per
Ken Dolitsky
Ken Dolitsky, an attorney at Robbins Geller Rudman & Dowd LLP, is a contact for investors regarding the Medpace class action lawsuit.
Importance 50 Sentiment 30
per
Michael Albert
Michael Albert, an attorney at Robbins Geller Rudman & Dowd LLP, is a contact for investors regarding the Medpace class action lawsuit.
Importance 50 Sentiment 30
per
Peretz Bronstein
Peretz Bronstein is a founding partner of Bronstein, Gewirtz & Grossman, LLC, and is involved in the class action lawsuit against Medpace.
Importance 40 Sentiment 50
govactor
United States — United States Securities and Exchange Commission
The United States — United States Securities and Exchange Commission's rules and acts are cited as the basis for the class action lawsuit against Medpace.
Importance 30 Sentiment 0
per
James Wilson
James Wilson, a partner at Faruqi & Faruqi, is encouraging investors who suffered losses in Medpace to contact him to discuss their legal options.
Importance 30 Sentiment 40
per
Nathan Miller
Nathan Miller is a Client Relations Manager at Bronstein, Gewirtz & Grossman, LLC, and is a contact for investors regarding the Medpace class action lawsuit.
Importance 20 Sentiment 30
+ 2 more entities View on Dashboard
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.